China SXT Pharmaceuticals, Inc. Increase (Decrease) in Accounts Receivable
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-01
| Period end | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|
| 2026-03-31 | -$291.13K 20-F · filed 2026-07-01 | |
| 2025-09-30 | -$100.20K 6-K · filed 2025-12-31 | |
| 2025-03-31 | $257.08K 20-F · filed 2026-07-01 | |
| 2024-09-30 | $303.26K 6-K · filed 2025-12-31 | |
| 2024-03-31 | $321.42K 20-F · filed 2026-07-01 | |
| 2023-09-30 | $72.97K 6-K · filed 2025-03-28 | |
| 2023-03-31 | -$912.95K 20-F · filed 2025-07-31 | |
| 2022-09-30 | $372.73K 6-K · filed 2024-04-05 | |
| 2022-03-31 | -$831.47K 20-F · filed 2024-08-13 | |
| 2021-09-30 | -$697.80K 6-K · filed 2023-02-24 | |
| 2021-03-31 | $519.24K 20-F · filed 2023-07-31 | |
| 2020-09-30 | $1.55M 6-K · filed 2022-01-14 | |
| 2020-03-31 | -$104.00K 20-F/A · filed 2023-05-19 | |
| 2019-09-30 | $664.34K 6-K · filed 2021-01-28 | |
| 2019-03-31 | $1.81M 20-F · filed 2021-08-13 | |
| 2018-09-30 | $1.57M 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | -$384.43K 20-F · filed 2020-07-31 | |
| 2017-03-31 | $942.97K 20-F · filed 2019-08-15 |